Control of surface wetting properties to produce strongly hydrophobic or hydrophilic effects is at the heart of many macro- and microfluidic applications. In this work, we have investigated coaxial electrospinning to produce core-sheath-structured nano/microfibers that combine different properties from individual core and sheath materials. Teflon AF is an amorphous fluoropolymer that is widely utilized as a hydrophobic material. Hydrophobic fluoropolymers are normally not electrospinnable because their low dielectric constant prevents sufficient charging for a solution to be electrospun. The first Teflon electrospun fibers are reported using coaxial electrospinning with Teflon AF sheath and poly(epsilon-caprolactone) (PCL) core materials. Using these core/sheath fibers, superhydrophobic and oleophobic membranes have been successfully produced. These coaxial fibers also preserve the core material properties as demonstrated with mechanical tensile tests. The fact that a normally nonelectrospinnable material such as Teflon AF has been successfully electrospun when combined with an electrospinnable core material indicates the potential of coaxial electrospinning to provide a new degree of freedom in terms of material combinations for many applications.
A novel dual drug delivery system is presented using triaxial structured nanofibers, which provides different release profiles for model drugs separately loaded in either the sheath or the core of the fiber. Homogenous, coaxial and triaxial fibers containing a combination of materials (PCL, polycaprolactone; PVP, polyvinylpyrrolidone) were fabricated. The drug release profiles were simulated using two color dyes (KAB, keyacid blue; KAU, keyacid uranine), whose release in physiological solution was measured using optical absorption as a function of time. To reach the level of 80% release of encapsulated dye from core, triaxial fibers with a PCL intermediate layer exhibited a ~24× slower release than that from coaxial fibers. At the same time, the hygroscopic sheath layer of the triaxial fibers provided an initial burst release (~ 80% within an hour) of a second dye as high as that from conventional single and coaxial fibers. The triaxial fiber membrane provides both a quick release from the outer sheath layer for short-term treatment and a sustained release from the fiber core for long-term treatment. The intermediate layer between inner core and outer sheath acts as a barrier to prevent leaching from the core, which can be especially important when the membranes are used in wet application. The formation of tri/multiaxially electrospun nanofibrous membranes will be greatly beneficial for biomedical applications by enabling different release profiles of two different drugs from a membrane.
The formation of fibers by electrospinning has experienced explosive growth in the past decade, recently reaching 4,000 publications and 1,500 patents per year. This impressive growth of interest is due to the ability to form fibers with a variety of materials, which lend themselves to a large and rapidly expanding set of applications. In particular, coaxial electrospinning, which forms fibers with multiple core−sheath layers from different materials in a single step, enables the combination of properties in a single fiber that are not found in nature in a single material. This article is a detailed review of coaxial electrospinning: basic mechanisms, early history and current status, and an in‐depth discussion of various applications (biomedical, environmental, sensors, energy, catalysis, textiles). We aim to provide readers who are currently involved in certain aspects of coaxial electrospinning research an appreciation of other applications and of current results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.